MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib-Reference-Cited by-同舟云学术

MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib

Published:2015 Issue: Volume:4 Page:e233
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Stiuso Paola,Potenza Nicoletta,Lombardi Angela,Ferrandino Ida,Monaco Antonio,Zappavigna Silvia,Vanacore Daniela,Mosca Nicola,Castiello Filomena,Porto Stefania,Addeo Raffaele,Prete Salvatore Del,De Vita Ferdinando,Russo Aniello,Caraglia Michele

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference41 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Updated treatment approach to hepatocellular carcinoma;Llovet;J Gastroenterol,2005

3. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy;Rossi;Cell Death Dis,2014

4. The PPAR-γ agonist troglitazone antagonizes survival pathways induced by STAT-3 in recombinant interferon-ß treated pancreatic cancer cells;Vitale;Biotechnol Adv,2012

5. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma;Critical Reviews in Oncology/Hematology;2024-08

2. MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway;Cell Death Discovery;2024-04-25

3. Analysis of MicroRNAs in Correlation to Astrocytoma;IFMBE Proceedings;2024

4. Exosomal microRNA profiling revealed enhanced autophagy suppression and anti-tumor effects of a combination of compound Phyllanthus urinaria and lenvatinib in hepatocellular carcinoma;Phytomedicine;2024-01

5. Targeting non-coding RNAs: Perspectives and challenges of in-silico approaches;European Journal of Medicinal Chemistry;2023-12